With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ...

The team at Orange BIOMED is working on a device that will allow people of color to get more accurate A1C readings, which is a blood test that measures blood sugar to diagnose and monitor diabetes.

Abbott Laboratories ABT faced industry-wide challenges that exerted pressure on its profit margins. Factors such as rising ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

The global glucose monitoring devices market was valued at USD 14.1 billion in 2023 and is expected to grow to USD 15.67 ...

As a competitive powerlifter, Nathan Zenero has a unique talent for lifting heavy things. He’s also taken on more than a few challenges in his life, including sports injuries and thyroid cancer.

Abbott NORTHAMPTON, MA / ACCESS Newswire / February 10, 2025 / Four out of 10 people living with diabetes miss appointments due to shame1. How can we change that?A lot of things we commonly hear about ...

The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...